Kenneth J Mukamal Selected Research

Magnesium

12/2014	Proton-pump inhibitor use is associated with lower urinary magnesium excretion.
10/2013	Response to Lowered magnesium in hypertension.
6/2013	Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study.
6/2013	Urinary and plasma magnesium and risk of ischemic heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth J Mukamal Research Topics

Disease

49	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
29	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2007
26	Insulin Resistance 06/2022 - 09/2005
23	Hypertension (High Blood Pressure) 01/2022 - 03/2004
18	Myocardial Infarction 01/2021 - 05/2002
17	Atherosclerosis 08/2021 - 12/2004
16	Inflammation (Inflammations) 01/2022 - 03/2004
14	Stroke (Strokes) 01/2022 - 03/2009
12	Dementia (Dementias) 01/2021 - 03/2003
11	Heart Failure 01/2021 - 03/2009
11	Type 2 Diabetes Mellitus (MODY) 11/2019 - 09/2007
10	Peripheral Arterial Disease 01/2019 - 11/2011
9	Atrial Fibrillation 01/2022 - 07/2012
9	Diabetes Mellitus 11/2018 - 04/2009
8	Obesity 01/2016 - 04/2008
7	Cognitive Dysfunction 01/2021 - 05/2011
6	Orthostatic Hypotension (Postural Hypotension) 01/2022 - 10/2018
6	Kidney Diseases (Kidney Disease) 10/2021 - 02/2016
6	Fibrosis (Cirrhosis) 10/2020 - 05/2014
6	Chronic Renal Insufficiency 10/2018 - 04/2012
5	Ischemic Stroke 01/2022 - 09/2005
4	Infarction (Infarctions) 01/2022 - 05/2002
4	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2016
4	Frailty 01/2021 - 06/2014
4	Chronic Disease (Chronic Diseases) 11/2016 - 05/2010
3	Brain Infarction 01/2022 - 01/2017
3	Weight Loss (Weight Reduction) 01/2022 - 05/2004
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2016
3	Pneumonia (Pneumonitis) 01/2021 - 02/2010
3	Critical Illness (Critically Ill) 10/2020 - 06/2015
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2015 - 04/2012
2	Liver Diseases (Liver Disease) 01/2022 - 06/2015
2	Syncope (Fainting) 01/2022 - 10/2019
2	Mobility Limitation (Difficulty Walking) 01/2021 - 12/2020
2	Gout 01/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2020
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 01/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2016
2	Albuminuria 11/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2005
17	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2010
15	LipidsIBA 01/2022 - 11/2007
14	C-Reactive ProteinIBA 01/2021 - 03/2004
13	ApolipoproteinsIBA 01/2021 - 03/2003
13	Insulin (Novolin)FDA Link 12/2020 - 10/2008
12	Nonesterified Fatty Acids (NEFA)IBA 06/2022 - 04/2012
12	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 05/2011
10	AdiponectinIBA 12/2020 - 10/2008
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2009
8	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 02/2010
8	Apolipoproteins E (ApoE)IBA 01/2022 - 09/2005
8	Lipoproteins (Lipoprotein)IBA 01/2022 - 07/2007
8	HDL LipoproteinsIBA 01/2022 - 11/2007
8	alpha-2-HS-GlycoproteinIBA 12/2020 - 05/2012
7	hydroxide ionIBA 01/2022 - 12/2013
7	SodiumIBA 01/2022 - 06/2013
7	HDL CholesterolIBA 12/2020 - 09/2005
6	CholesterolIBA 01/2022 - 11/2007
6	Fibrinogen (Factor I)FDA Link 12/2019 - 03/2004
6	Interleukin-6 (Interleukin 6)IBA 11/2019 - 12/2004
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 08/2008
5	Coffee FDA Link 01/2021 - 06/2004
5	DiureticsIBA 01/2020 - 11/2014
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2019 - 11/2014
5	Apolipoprotein C-IIIIBA 01/2019 - 01/2017
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 05/2014
4	AlbuminsIBA 12/2020 - 03/2004
4	CreatinineIBA 11/2020 - 04/2012
4	Biological ProductsIBA 01/2020 - 09/2013
4	CalciumIBA 12/2019 - 12/2008
4	EnzymesIBA 12/2019 - 01/2016
4	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2019 - 06/2014
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 01/2017
4	VLDL LipoproteinsIBA 05/2018 - 07/2007
4	Vitamin D FDA LinkGeneric 10/2017 - 12/2013
4	PotassiumIBA 01/2016 - 06/2013
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016 - 02/2010
4	Fibroblast Growth Factor-23IBA 07/2015 - 07/2012
4	Collagen Type III (Type III Collagen)IBA 04/2015 - 05/2014
4	procollagen Type III-N-terminal peptide (PIIP)IBA 04/2015 - 05/2014
4	MagnesiumIBA 12/2014 - 06/2013
4	TeaIBA 04/2012 - 05/2002
3	oxidized low density lipoproteinIBA 01/2022 - 07/2007
3	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2021 - 11/2010
3	Trans Fatty AcidsIBA 11/2021 - 06/2015
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 05/2013
3	Vitamin E FDA LinkGeneric 01/2021 - 10/2017
3	Docosahexaenoic AcidsIBA 01/2021 - 11/2010
3	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 03/2014
3	Triglycerides (Triacylglycerol)IBA 12/2020 - 01/2015
3	Folic Acid (Vitamin M)FDA LinkGeneric 02/2020 - 12/2008
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2009
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2019 - 01/2016
3	Hormones (Hormone)IBA 01/2018 - 05/2016
3	Cystatin CIBA 06/2014 - 06/2012
2	Dietary Fiber FDA Link 01/2022 - 04/2014
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 11/2010
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 03/2004

Therapy/Procedure

9	Therapeutics 01/2021 - 08/2008
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2009 - 02/2006